PAAFF
Pharmaust Ltd.

0
Mkt Cap
$72.17M
Volume
10,000.00
52W High
$0.10
52W Low
$0.0686
PE Ratio
-3.12
PAAFF Fundamentals
Price
$0.0686
Prev Close
$0.07
Open
$0.0686
50D MA
$0.011
Beta
0.00
Avg. Volume
0.00
EPS (Annual)
-$0.0221
P/B
18.29
Loading...
Loading...
Neurizon Therapeutics Ltd. engages in the business of developing own drug discovery intellectual property for the treatment of different types of cancers, neurological diseases, and viral infections; and providing highly specialized medicinal and synthetic chemistry services on a contract basis to clients. It operates under the Corporate and Research, and Pharmaceutical-Epichem segments. The Corporate and Research segment includes corporate overhead expenses. The Pharmaceutical-Epichem segment provides products and services in synthetic and medicinal chemistry to the drug discovery and pharmaceutical industries. The company was founded on December 2003 and is headquartered in Claremont, Australia.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Neurizon Therapeutics Ltd.?
What is the 52-week high for Neurizon Therapeutics Ltd.?
What is the 52-week low for Neurizon Therapeutics Ltd.?
What is Neurizon Therapeutics Ltd. stock price today?
What was Neurizon Therapeutics Ltd. stock price yesterday?
What is the PE ratio of Neurizon Therapeutics Ltd.?
What is the Price-to-Book ratio of Neurizon Therapeutics Ltd.?
What is the 50-day moving average of Neurizon Therapeutics Ltd.?

Latest PAAFF News

View
No PAAFF news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.